Positive Topline Results from the Phase 3 MonumenTAL-6 Trial: Teclistamab Plus Talquetamab, Talquetamab Plus Pomalidomide Improved PFS and OS vs Standard of Care in RRMM Read more about Positive Topline Results from the Phase 3 MonumenTAL-6 Trial: Teclistamab Plus Talquetamab, Talquetamab Plus Pomalidomide Improved PFS and OS vs Standard of Care in RRMMAdd new comment
July 2026 – Myeloma News from the Journals Read more about July 2026 – Myeloma News from the JournalsAdd new comment
Coalition to Improve Access to Cancer Care Applauds Reintroduction of the Cancer Drug Parity Act Read more about Coalition to Improve Access to Cancer Care Applauds Reintroduction of the Cancer Drug Parity ActAdd new comment
FAQs on the FDA Approval of Sarclisa SC (isatuximab-irfc) for Myeloma Indications Read more about FAQs on the FDA Approval of Sarclisa SC (isatuximab-irfc) for Myeloma IndicationsAdd new comment
Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy Read more about Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance TherapyAdd new comment
FDA Accepts New Drug Application for Mezigdomide in Combination with Carfilzomib and Dexamethasone as Treatment for Relapsed/Refractory Myeloma Read more about FDA Accepts New Drug Application for Mezigdomide in Combination with Carfilzomib and Dexamethasone as Treatment for Relapsed/Refractory Myeloma Add new comment
Sarclisa (isatuximab-irfc) Approved as a Subcutaneous Injection for Multiple Myeloma by the FDA Read more about Sarclisa (isatuximab-irfc) Approved as a Subcutaneous Injection for Multiple Myeloma by the FDAAdd new comment
CHMP-EMA Issues Positive Opinion on Teclistamab for Relapsed/Refractory Myeloma, Adopts Changes to Marketing Authorization Read more about CHMP-EMA Issues Positive Opinion on Teclistamab for Relapsed/Refractory Myeloma, Adopts Changes to Marketing Authorization Add new comment
June 2026 – Myeloma News from the Journals Read more about June 2026 – Myeloma News from the JournalsAdd new comment
